- 011-3757 9730
- info@clonex.com.my
- Arte+ Condo, Jalan Ampang, 55000, Wilayah Persekutuan, Kuala Lumpur. Malaysia
At CLONEX, we operate at the intersection of biology and capital markets, identifying opportunities where breakthrough science meets market inefficiency.
CLONEX Biotech Trading Initiative is a specialized division dedicated to navigating the complex and high-potential world of biotechnology markets. Unlike traditional equity strategies, we focus exclusively on non-pharmaceutical biotech companies—where innovation cycles, clinical breakthroughs, and emerging technologies create unique trading opportunities
Biotech trading is high risk and volatile.
Past performance ≠ future results
Trading around clinical trials, FDA decisions, and major announcements.
Identifying companies with scalable biotechnology technologies.
Monitoring funding, dilution, and institutional investment flows.
Early identification of disruptive biotech startups and IPO opportunities.
Biotech is one of the fastest-growing sectors globally.
invested annually into biotech innovation
of companies advancing clinical pipelines globally
transforming healthcare and biotechnology
Access high-growth opportunities in the future of biology. Science drives innovation while we navigate the markets.
Copyright 2025. All rights reserved by CLONEX (M) SDN. BHD. SSM: 202301051929 (1545843-W).
